tiprankstipranks
Advertisement
Advertisement
Dr. Reddy’s announces first-to-market launch of Bosutinib Tablets 400mg
PremiumThe FlyDr. Reddy’s announces first-to-market launch of Bosutinib Tablets 400mg
18d ago
Alvotech resubmits AVT05 BLAs to FDA
Premium
The Fly
Alvotech resubmits AVT05 BLAs to FDA
28d ago
Dr. Reddy’s Schedules June 2026 Analyst and Investor Meetings in Mumbai and Hyderabad
Premium
Company Announcements
Dr. Reddy’s Schedules June 2026 Analyst and Investor Meetings in Mumbai and Hyderabad
29d ago
Dr. Reddy’s launches generic Semaglutide injection in Canada
PremiumThe FlyDr. Reddy’s launches generic Semaglutide injection in Canada
2M ago
Dr. Reddy’s Launches First Generic Semaglutide Injection in Canada After Health Canada Nod
Premium
Company Announcements
Dr. Reddy’s Launches First Generic Semaglutide Injection in Canada After Health Canada Nod
2M ago
Dr. Reddy’s Earnings Call: Growth vs. Margin Pain
Premium
Company Announcements
Dr. Reddy’s Earnings Call: Growth vs. Margin Pain
2M ago
Dr. Reddy’s Schedules May 2026 Investor Conferences in Mumbai and Singapore
PremiumCompany AnnouncementsDr. Reddy’s Schedules May 2026 Investor Conferences in Mumbai and Singapore
2M ago
Dr. Reddy’s Grants Over 1.19 Million Employee Stock Options Under ESOP and ADR Schemes
Premium
Company Announcements
Dr. Reddy’s Grants Over 1.19 Million Employee Stock Options Under ESOP and ADR Schemes
2M ago
Dr. Reddy’s announces Health Canada approval for Semaglutide Injection
Premium
The Fly
Dr. Reddy’s announces Health Canada approval for Semaglutide Injection
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100